On 1 October, infertility treatment clinic Invicta implemented a new AI tool – the AIOO application, which was co-created by MIM Solutions. AIOO predicts the likely number of mature ova obtainable during the in-vitro process. The solution, which is powered by artificial intelligence, bases its prognosis on the patient’s individual laboratory test results and her treatment history.
Together with the application, INVICTA has created a test that allows the assessment of a patient’s genetic predisposition. The test makes AIOO’s prognosis of the number of mature oocytes even more accurate.
We think the biggest challenge is actually cultural, in getting scientists and data scientists to work together as equal partners. In many companies, one group